Basilar artery (BA) occlusion is generally believed to have a high mortality. A favorable outcome is rarely reported. A consecutive series of 20 survivors with angiographically proven symptomatic BA occlusion not treated with thrombolysis or selected for outcome were analyzed for clinical presentation and neuroradiologic features to find outcome predictors. Long-term functional outcome (Rankin scale) was good in 12 (60%), moderate in 4 (20%), and poor in 4 (20%) patients who had complete mid-segmental BA occlusions and bilateral large pontine infarcts. Prominent retrograde collateral supply from the carotids and/or anterograde from the cerebellar arteries was present in all patients with adequate angiographic studies (n = 18). BA occlusion was proximal in 12, mid-segmental in 7, and distal in 1 patient. Stroke etiology was considered atherothrombotic in 14 (70%), embolic in 2 (10%), and related to migraine in 4 (20%). Clinical outcome following BA occlusion is more heterogenous than usually presumed and influenced by the temporal course, length of BA occlusion, availability of collateral circulation, and extent of brainstem infarction. The etiology of benign BA occlusion is mostly local thrombosis.

Keywords:
Basilar artery occlusion, Survival, Long-term follow-up, Outcome predictors, Collaterals
This content is only available via PDF.
© 1995 S. Karger AG, Basel
1995
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.